Your browser doesn't support javascript.
loading
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
Waclawiczek, Alexander; Leppä, Aino-Maija; Renders, Simon; Stumpf, Karolin; Reyneri, Cecilia; Betz, Barbara; Janssen, Maike; Shahswar, Rabia; Donato, Elisa; Karpova, Darja; Thiel, Vera; Unglaub, Julia M; Grabowski, Susanna; Gryzik, Stefanie; Vierbaum, Lisa; Schlenk, Richard F; Röllig, Christoph; Hundemer, Michael; Pabst, Caroline; Heuser, Michael; Raffel, Simon; Müller-Tidow, Carsten; Sauer, Tim; Trumpp, Andreas.
Affiliation
  • Waclawiczek A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Leppä AM; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Renders S; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Stumpf K; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Reyneri C; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Betz B; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Janssen M; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Shahswar R; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Donato E; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Karpova D; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Thiel V; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Unglaub JM; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Grabowski S; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Gryzik S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Vierbaum L; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schlenk RF; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Röllig C; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Hundemer M; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Pabst C; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Heuser M; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Raffel S; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Müller-Tidow C; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Sauer T; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Trumpp A; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Cancer Discov ; 13(6): 1408-1427, 2023 06 02.
Article in En | MEDLINE | ID: mdl-36892565
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proteomics Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Discov Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proteomics Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Discov Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United States